ZERO's Commitment to Health Equity ZERO Prostate Cancer is dedicated to ensuring that every person, no matter their race, financial situation, or where they live, has a fair and just chance to prevent, detect, treat, and survive prostate cancer. This important goal is known as health equity. Play Video Close The importance of health equity If you've ever dealt with the healthcare system in the United States, you might have noticed that where we live affects the healthcare we have access to. Similarly, where we work can determine our health insurance coverage. Additionally, factors like race can also affect the healthcare we receive, including the quality of primary and specialized care.These differences in health and healthcare also exist in the prostate cancer space. They play a part in why people from communities that haven't been treated fairly in the past often have worse health results.ZERO's goal is to reduce the gaps that make it harder for people from historically underrepresented communities to get fair and just care and support while battling prostate cancer. To achieve that, our organization is working to provide assistance across three main pillars: education and awareness, patient support and financial assistance, and advocacy and research. ZERO's three pillars of impact As part of our efforts to achieve health equity in prostate cancer, ZERO is focused on improving different parts of the healthcare system. We start by focusing on the three main ways people affected by prostate cancer look for help and care: Education and awareness We will work together with new and existing partners in the healthcare system. We will also work to form new partnerships and strengthen current partnerships with organizations in local communities, including the faith-based community, national Panhellenic fraternities, historically Black colleges and universities, and federally qualified health centers. Patient support and financial assistance We will work with community partners and leaders to increase awareness of available patient resources and programs. We will also work to continue creating and expanding our organization's support and assistance programs, especially for the Black community, people of color, and other historically underrepresented groups. Advocacy and research We will team up with companies, schools, and the government to make more people in the Black community and other historically underrepresented communities aware of clinical trials. We will also address the lack of trust between these communities and the medical system. Additionally, we will make sure that clinical trials include people of different races. ZERO's Health Equity Task Force In order to make sure that our work towards health equity includes input from doctors, patients, caregivers, and those affected by prostate cancer, ZERO has created the Health Equity Task Force. This diverse group, including prostate cancer survivors, healthcare experts, and community leaders, guides and supports our programs and initiatives, ensuring that our work is focused on achieving health equity for all. Full-time Open Roles Bettina Drake, PhD, MPH Professor of Surgery Rep. La Shawn K. Ford 8th District Representative Dr. Stanley Frencher, Jr. Director, Surgical Outcomes & Quality Avirup Guha, MD, MPH, RPVI, FICOS, FACC Inaugural Director of Cardio-Oncology Brian A. Jones Member, Board of Directors Men's Health Co-Chair Landi Maduro Director/Producer Joseph Osborne, MD, PhD Chief of Molecular Imaging & Therapeutics LaMonica Stewart, PhD Professor, Department of Biochemistry, Cancer Biology, Neuroscience & Pharmacology Sherrie Wallington, PhD Associate Professor, Health Disparities & Oncology Teedra Bernard Member, Board of Directors Stacy Loeb, MD Professor, Urology & Population Health Jon Poindexter Kelvin Moses, MD, PhD Associate Professor, Urologic Surgery
Play Video Close The importance of health equity If you've ever dealt with the healthcare system in the United States, you might have noticed that where we live affects the healthcare we have access to. Similarly, where we work can determine our health insurance coverage. Additionally, factors like race can also affect the healthcare we receive, including the quality of primary and specialized care.These differences in health and healthcare also exist in the prostate cancer space. They play a part in why people from communities that haven't been treated fairly in the past often have worse health results.ZERO's goal is to reduce the gaps that make it harder for people from historically underrepresented communities to get fair and just care and support while battling prostate cancer. To achieve that, our organization is working to provide assistance across three main pillars: education and awareness, patient support and financial assistance, and advocacy and research.
ZERO's three pillars of impact As part of our efforts to achieve health equity in prostate cancer, ZERO is focused on improving different parts of the healthcare system. We start by focusing on the three main ways people affected by prostate cancer look for help and care: Education and awareness We will work together with new and existing partners in the healthcare system. We will also work to form new partnerships and strengthen current partnerships with organizations in local communities, including the faith-based community, national Panhellenic fraternities, historically Black colleges and universities, and federally qualified health centers. Patient support and financial assistance We will work with community partners and leaders to increase awareness of available patient resources and programs. We will also work to continue creating and expanding our organization's support and assistance programs, especially for the Black community, people of color, and other historically underrepresented groups. Advocacy and research We will team up with companies, schools, and the government to make more people in the Black community and other historically underrepresented communities aware of clinical trials. We will also address the lack of trust between these communities and the medical system. Additionally, we will make sure that clinical trials include people of different races.
ZERO's Health Equity Task Force In order to make sure that our work towards health equity includes input from doctors, patients, caregivers, and those affected by prostate cancer, ZERO has created the Health Equity Task Force. This diverse group, including prostate cancer survivors, healthcare experts, and community leaders, guides and supports our programs and initiatives, ensuring that our work is focused on achieving health equity for all. Full-time Open Roles Bettina Drake, PhD, MPH Professor of Surgery Rep. La Shawn K. Ford 8th District Representative Dr. Stanley Frencher, Jr. Director, Surgical Outcomes & Quality Avirup Guha, MD, MPH, RPVI, FICOS, FACC Inaugural Director of Cardio-Oncology Brian A. Jones Member, Board of Directors Men's Health Co-Chair Landi Maduro Director/Producer Joseph Osborne, MD, PhD Chief of Molecular Imaging & Therapeutics LaMonica Stewart, PhD Professor, Department of Biochemistry, Cancer Biology, Neuroscience & Pharmacology Sherrie Wallington, PhD Associate Professor, Health Disparities & Oncology Teedra Bernard Member, Board of Directors Stacy Loeb, MD Professor, Urology & Population Health Jon Poindexter Kelvin Moses, MD, PhD Associate Professor, Urologic Surgery
